Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
Blood Cells, Molecules & Diseases|October 23, 2018
Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantationJunghoon Shin, Kisoon Dan, Dohyun Han, et al.
Nuclear Medicine and Molecular Imaging|September 2, 2014
Prognostic Value of Metabolic Tumor Volume Estimated by (18) F-FDG Positron Emission Tomography/Computed Tomography in Patients with Diffuse Large B-Cell Lymphoma of Stage II or III DiseaseJihyun Kim, Junshik Hong, Seog Gyun Kim, et al.
Annals of Hematology|October 20, 2011
Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphomaJunshik Hong, Yukyung Lee, Yeonjeong Park, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2012
A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapySun Jin Sym, Junshik Hong, Jinny Park, et al.
Acta Haematologica|September 7, 2013
Prognostic role of serum lactate dehydrogenase beyond initial diagnosis: a retrospective analysis of patients with diffuse large B cell lymphomaJunshik Hong, Hyun-Hwa Yoon, Hee Kyung Ahn, et al.
Investigational New Drugs|August 23, 2014
Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitorsHyun Sun Woo, Hee Kyung Ahn, Ha Yeon Lee, et al.
Cancer Research and Treatment|April 2, 2016
Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based ChemotherapyInkeun Park, Seung Joon Choi, Young Saing Kim, et al.
Nature Communications|January 10, 2025
Increased local DNA methylation disorder in AMLs with DNMT3A-destabilizing variants and its clinical implicationDohoon Lee, Bonil Koo, Seokhyeon Kim, et al.
Cancer Research and Treatment|September 27, 2023
A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia PatientsJa Min Byun, Junghoon Shin, Sang-A Kim, et al.
International Journal of Hematology|October 10, 2013
Frequency of KRAS mutations in adult Korean patients with acute myeloid leukemiaMi-Jung Park, Soon-Ho Park, Pil-Whan Park, et al.
Pageof 18